Aminopyrimidines as Syk inhibitors
US9290490B2 · kind B2 · utility
9Cited by
25References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2012 |
| Grant date | Mar 22, 2016 |
| Priority date | — |
| Expiry date | Jul 8, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel pyrimidine amines of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.